Follicular Unit Extraction in Management of Secondary Cicatricial Alopecia

    August 2021 in “ Al-Azhar International Medical Journal (Print) ”
    Mahmood Mohaamd Saeed, Abdel Monem Hussein Hoota, Abdel Nasser Abdel Rahman Khallaf
    Image of study
    TLDR Hair transplantation is effective for treating cicatricial alopecia with fewer anesthesia risks, scars, and recovery time.
    The study "Follicular Unit Extraction in Management of Secondary Cicatricial Alopecia" conducted by Mahmood Saeed, Abdel Monem Hoota, and Abdel Nasser Khallaf from Al-Azhar University, Egypt, involved 20 patients with secondary cicatricial alopecia. The results showed that 80% of the patients were males and 20% were females, with an average age of 18.85 years. The general outcome was rated as bad for 10% of the patients, good for 30%, and very good for 60%. In terms of hair density, 5% had poor results, 65% good, and 30% very good. Postoperative scars were low in 90% of the patients and high in 10%. Hair direction was bad in 20% of the cases, good in 55%, and very good in 25%. 45% of the patients required another surgery. The study concluded that hair transplantation is beneficial for treating cicatricial alopecia, with fewer risks during anesthesia, fewer post-operative scars, and less recovery time than traditional hair restoration methods.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 152 results

      community How is verteporfin doing in trials?

      in Chat  9 upvotes 10 months ago
      The conversation is about the progress of verteporfin in hair loss trials, with users expressing curiosity about its effectiveness and updates. Specific treatments mentioned include FUE (Follicular Unit Extraction) combined with verteporfin, with one reported case of donor area regrowth after a year, and three patients being monitored post-treatment by Dr. Bloxham with monthly updates on YouTube.

      community Verteporfin and Microneedling

      in Treatments 3 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Related Research

    1 / 1 results